Dr. Konstantin Popov’s lab is pioneering the use of artificial intelligence to design new drug compounds for diseases like tuberculosis and cancer. By combining AI modeling with hands-on chemistry and biology, Popov’s team has created powerful, biologically feasible molecules far faster than traditional methods allow. Beyond research, Popov developed DELi, the first open-source software for analyzing DNA-encoded library data, to make advanced AI tools accessible to scientists worldwide.
read more: Drug discovery center integrating AI for big impact